September 1, 2023

Tong Zhang joined He lab

Study direction: The effect of epigenetic mutations on the prognosis of leukemia was analyzed by bioinformatics at the single-cell level

September 1, 2022

Xubin Chen joined He lab

Study direction: Developing novel epigenetic liquid biopsy technologies

September 1, 2022

Kexin Xian joined He lab

Study direction: Spatial-temporal reconstruction of cellular dynamics and lineage specification during mouse gastrulation using in toto live imaging.

September 1, 2021

Xiaoxuan Meng joined He lab

Study direction: Epigenomic editing reprograms human totipotent stem cells to hematopoitic cells

September 1, 2021

Shuaifang Yan joined He lab

Study direction: Long-term live imaging reconstructs in toto cell fate decisions underlying mammalian gastrulation.

September 1, 2021

Chao Dong joined He lab

Study direction: Developing single-cell multi-omics technologies to analyze drug targets and multimodal epigenomics for clinical drug efficacy evaluation and the study of tumor resistance mechanisms.

September 1, 2019

Min Liu joined He lab

Study direction: Engineering leukemia stem cells to overcome differentiation blockade in acute myeloid leukemia.

November 20, 2019

SINGLE-CELL CHIP-SEQ TECHNOLOGY WORKSHOP 

Sponsored by the Institute of Molecular Medicine of Peking University and undertaken by He Aibin’s laboratory, the four-day “Single-cell ChIP-seq Technology Workshop” ended successfully in the Comprehensive Research Building of Peking University

September 1, 2018

Yaxi Liu joined He lab

Study direction: large-scale single-cell multiomic data engineering and analysis focusing on development and ageing.

September 1, 2016

Li Chen joined He lab

Study direction: Deciphering mechanisms and manipulations of cell fates from epigenomes.